Risk factors for cardiovascular disease in patients with subclinical hypothyroidism

被引:59
作者
Toruner, Fusun [1 ]
Altinova, Alev E. [1 ]
Karakoc, Ayhan [1 ]
Yetkin, Ilhan [1 ]
Ayvaz, Goksun [1 ]
Cakir, Nuri [1 ]
机构
[1] Gazi Univ, Fac Med, Dept Endocrinol & Metab, Ankara, Turkey
关键词
cardiovascular risk; lipids; lipoprotein; subclinical hypothyroidism; thyroid hormones;
D O I
10.1007/s12325-008-0053-7
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 [基础医学];
摘要
Introduction: The relationship between subclinical hypothyroidism (SCH) and cardiovascular disease is not fully understood. We investigated risk factors for cardiovascular disease (lipid profile, lipoproteins, insulin resistance, C-reactive protein [CRP] homocysteine [Hcy] and fibrinogen levels) and their relationships with thyroid hormones in SCH patients and controls. Methods: Thirty-eight SCH patients and 44 controls were enrolled in this study. No patients had any substantial confounding medical conditions (including diabetes mellitus or coronary heart disease) or were taking thyroidrelated medication. Results: Serum total cholesterol (P < 0.05), low-density lipoprotein cholesterol (P < 0.05) and triglycerides (P < 0.001) were higher in patients with SCH than in controls. Serum lipoprotein(a) (Lp[a]) levels were higher in SCH subjects but this difference did not reach statistical significance (P=0.07). No significant differences were noted in CRP, Hcy, fibrinogen, high-density lipoprotein cholesterol, apolipoprotein A-1, apolipoprotein B (Apo B) or insulin resistance between patients with SCH and controls (in all cases, P > 0.05). Free triiodothyronine (FT3) negatively correlated with Apo B (r=.0.46, P=0.005) and Lp(a) (r=.0.31, P=0.03) in patients with SCH and negatively correlated with Lp(a) (r=.0.30, P=0.04) in controls. All of these parameters were comparable between patients with thyroid-stimulating hormone (TSH) > 10 mu IU/ml and TSH < 10 mu IU/ml (in SCH patients, P > 0.05). Conclusion: Our results suggest that SCH is associated with some lipid and lipoprotein abnormalities. Our results also suggest that this association does not depend on the subject's TSH level.
引用
收藏
页码:430 / 437
页数:8
相关论文
共 36 条
[1]
Effect of L-thyroxine therapy on lipoprotein fractions in overt and subclinical hypothyroidism, with special reference to lipoprotein(a) [J].
Arem, R ;
Escalante, DA ;
Arem, N ;
Morrisett, JD ;
Patsch, W .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (12) :1559-1563
[2]
Hypothyroidism as a risk factor for cardiovascular disease [J].
Biondi, B ;
Klein, I .
ENDOCRINE, 2004, 24 (01) :1-13
[3]
Elevated C-reactive protein and homocysteine values:: cardiovascular risk factors in hypothyroidism?: A cross-sectional and a double-blind, placebo-controlled trial [J].
Christ-Crain, M ;
Meier, C ;
Guglielmetti, M ;
Huber, PR ;
Riesen, W ;
Staub, JJ ;
Müller, B .
ATHEROSCLEROSIS, 2003, 166 (02) :379-386
[4]
Effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: A quantitative review of the literature [J].
Danese, ND ;
Ladenson, PW ;
Meinert, CL ;
Powe, NR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (09) :2993-3001
[5]
Homocysteine: A risk factor for cardiovascular disease in subclinical hypothyroidism? [J].
Deicher, R ;
Vierhapper, H .
THYROID, 2002, 12 (08) :733-736
[6]
Thyroid disease and lipids [J].
Duntas, LH .
THYROID, 2002, 12 (04) :287-293
[7]
Lipid profile in subclinical hypothyroidism: is L-thyroxine substitution beneficial? [J].
Efstathiadou, Z ;
Bitsis, S ;
Milionis, HJ ;
Kukuvitis, A ;
Bairaktari, ET ;
Elisaf, MS ;
Tsatsoulis, A .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2001, 145 (06) :705-710
[8]
[9]
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[10]
Subclinical thyroid dysfunction: A joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society [J].
Gharib, H ;
Tuttle, RM ;
Baskin, HJ ;
Fish, LH ;
Singer, PA ;
McDermott, MT .
THYROID, 2005, 15 (01) :24-28